Role of HLA-G on HIV Evasion of NK Cells
HLA-G 在 NK 细胞逃避 HIV 中的作用
基本信息
- 批准号:8138941
- 负责人:
- 金额:$ 6.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-20 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAutologousBindingCD4 Positive T LymphocytesCD8B1 geneCell physiologyCell surfaceCellsCytotoxic T-LymphocytesDataDown-RegulationEndoplasmic ReticulumEnzyme-Linked Immunosorbent AssayEventFetal TissuesG CellsHIVHIV AntigensHIV InfectionsHIV-1HLA AntigensHLA G antigenHistocompatibility Antigens Class IImmune responseImmunologic SurveillanceLymphocyteMembraneModelingMolecularNatural Killer CellsPeptidesPopulationProductionProteinsRNA InterferenceRefractoryReportingResistanceRoleSignal TransductionSmall Interfering RNASurfaceT-LymphocyteTAC1 geneTestingTranscriptUp-RegulationViralbasecell killingcytotoxicinfected B cellinsightkillingslymphoblastpreventreceptorresponsetrophoblast
项目摘要
DESCRIPTION (provided by applicant): HIV-1 avoids destruction by HIV-antigen specific cytotoxic T-lymphocytes (CTL) by decreasing the cell surface expression of human leukocyte antigen (HLA)-A and HLA-B, which are needed to trigger CTL. Natural killer (NK) cells, however, can destroy cells lacking MHC class I molecules since these molecules inhibit NK cell killing. Despite this fact, NK cells are unable to kill HIV-infected cells. Our long-term objective is to determine how HIV prevents NK cells from destroying the infected cells, even though the conditions for the NK cell cytotoxic response appear optimal. One explanation for the inability of NK cells to kill HIV- infected cell is the presence of HLA-C and HLA-E on the infected cell surface. However, HLA-C and HLA-E only prevent a subset of NK cells from killing HIV-infected cells. Another explanation for the lack of NK cell killing is that HIV-1 induces the expression of HLA-G on activated CD4+ T-cells. HLA-G inhibits NK cell cytotoxic responses. The central hypothesis of this proposal is that HIV prevents NK from killing infected cells and controlling viral replication by inducing the expression of HLA-G. To evaluate our objective, we will determine the role of HLA-G cell surface expression, in the context of HIV infection, in disabling NK cell function, and to dissect the required signaling events. This will be accomplished by directing small interfering (si)RNA to HLA-G in HIV-infected cells, and determining the ability of NK cells to become activated and kill HIV-infected cells with decreased HLA-G surface expression. We will also determine the mechanisms by which HIV infection of CD4+ cells induces surface expression of HLA-G. Finally, we will determine the effect of soluble HLA-G secreted by HIV-infected cells on NK cell cytotoxic responses. The overall significance of this study is to provide insight into the mechanism important for allowing HIV to counter cellular immune responses that are differentially regulated by MHC class I molecules.
描述(由申请人提供):HIV-1通过降低人类白细胞抗原(HLA)-A和HLA-B的细胞表面表达来避免HIV抗原特异性细胞毒性T淋巴细胞(CTL)的破坏,而人类白细胞抗原(HLA)-A和HLA-B是触发CTL所必需的。然而,自然杀伤(NK)细胞可以破坏缺乏MHC I类分子的细胞,因为这些分子抑制NK细胞杀伤。尽管如此,NK细胞无法杀死HIV感染的细胞。我们的长期目标是确定HIV如何阻止NK细胞破坏受感染的细胞,即使NK细胞细胞毒性反应的条件似乎是最佳的。NK细胞不能杀死HIV感染的细胞的一种解释是在感染的细胞表面上存在HLA-C和HLA-E。然而,HLA-C和HLA-E只能阻止一部分NK细胞杀死HIV感染的细胞。缺乏NK细胞杀伤的另一种解释是HIV-1诱导活化的CD 4 + T细胞上HLA-G的表达。HLA-G抑制NK细胞的细胞毒性应答。该建议的中心假设是,HIV通过诱导HLA-G的表达来阻止NK杀死感染的细胞并控制病毒复制。为了评估我们的目标,我们将确定HLA-G细胞表面表达的作用,在HIV感染的背景下,在禁用NK细胞功能,并剖析所需的信号事件。这将通过将小干扰(si)RNA定向到HIV感染细胞中的HLA-G,并确定NK细胞变得活化并杀死具有降低的HLA-G表面表达的HIV感染细胞的能力来实现。我们还将确定HIV感染CD 4+细胞诱导HLA-G表面表达的机制。最后,我们将确定HIV感染细胞分泌的可溶性HLA-G对NK细胞细胞毒性反应的影响。这项研究的总体意义是提供了重要的机制,让艾滋病毒对抗细胞免疫反应的差异调节的MHC I类分子的洞察。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edward Barker其他文献
Edward Barker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edward Barker', 18)}}的其他基金
Harnessing adaptive NK cell transfer to deplete viral reservoirs
利用适应性 NK 细胞转移来耗尽病毒库
- 批准号:
10393660 - 财政年份:2021
- 资助金额:
$ 6.28万 - 项目类别:
Harnessing adaptive NK cell transfer to deplete viral reservoirs
利用适应性 NK 细胞转移来耗尽病毒库
- 批准号:
10597044 - 财政年份:2021
- 资助金额:
$ 6.28万 - 项目类别:
Switch from homeostatic to inflammatory cytokines by NK/ILC in HIV-infected gut
HIV 感染肠道中 NK/ILC 从稳态细胞因子转变为炎性细胞因子
- 批准号:
9074923 - 财政年份:2015
- 资助金额:
$ 6.28万 - 项目类别:
Switch from homeostatic to inflammatory cytokines by NK/ILC in HIV-infected gut
HIV 感染肠道中 NK/ILC 从稳态细胞因子转变为炎性细胞因子
- 批准号:
9127087 - 财政年份:2015
- 资助金额:
$ 6.28万 - 项目类别:
Vpu inhibits NK cell function through down regulation of NTB-A
Vpu 通过下调 NTB-A 抑制 NK 细胞功能
- 批准号:
8281825 - 财政年份:2011
- 资助金额:
$ 6.28万 - 项目类别:
Modulation of surface markers by HIV-1 Vpu/Vpr and sensitivity to NK cell lysis
HIV-1 Vpu/Vpr 对表面标志物的调节以及对 NK 细胞裂解的敏感性
- 批准号:
7760295 - 财政年份:2009
- 资助金额:
$ 6.28万 - 项目类别:
Modulation of surface markers by HIV-1 Vpu/Vpr and sensitivity to NK cell lysis
HIV-1 Vpu/Vpr 对表面标志物的调节以及对 NK 细胞裂解的敏感性
- 批准号:
7897741 - 财政年份:2009
- 资助金额:
$ 6.28万 - 项目类别:
Vpu inhibits NK cell function through down regulation of NTB-A
Vpu 通过下调 NTB-A 抑制 NK 细胞功能
- 批准号:
8263260 - 财政年份:2006
- 资助金额:
$ 6.28万 - 项目类别:
相似海外基金
Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
- 批准号:
MR/Y019458/1 - 财政年份:2024
- 资助金额:
$ 6.28万 - 项目类别:
Research Grant
Fabrication and Evaluation of Poly(glycerol sebacate) based small diameter vascular graft as a potent substitution for autologous vessels
基于聚(甘油癸二酸酯)的小直径血管移植物作为自体血管有效替代品的制造和评估
- 批准号:
2897580 - 财政年份:2023
- 资助金额:
$ 6.28万 - 项目类别:
Studentship
Autologous Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Femoral Head
自体骨髓抽吸浓缩液治疗股骨头坏死
- 批准号:
10658324 - 财政年份:2023
- 资助金额:
$ 6.28万 - 项目类别:
Identifying multimodal biomarkers for autologous serum tears in the treatment of chronic postoperative ocular pain
识别治疗慢性术后眼痛的自体血清泪液的多模式生物标志物
- 批准号:
10794761 - 财政年份:2023
- 资助金额:
$ 6.28万 - 项目类别:
SBIR Phase II: An Injectable Protein Matrix to Enhance the Stability of Autologous Fat Grafts
SBIR II 期:可注射蛋白质基质,增强自体脂肪移植物的稳定性
- 批准号:
2304430 - 财政年份:2023
- 资助金额:
$ 6.28万 - 项目类别:
Cooperative Agreement
MICA: Strategy for heart repair in Duchenne Muscular Dystrophy (DMD) using genetically engineered autologous Mesoangioblasts
MICA:利用基因工程自体中成血管细胞修复杜氏肌营养不良症 (DMD) 的心脏的策略
- 批准号:
MR/X00466X/1 - 财政年份:2023
- 资助金额:
$ 6.28万 - 项目类别:
Fellowship
Application of Autologous Connective Tissue Sheets Created in Patients' Bodies to Pediatric Cardiac Valvuloplasty and Development of Dedicated Molds
患者体内自体结缔组织片在小儿心脏瓣膜成形术中的应用及专用模具的开发
- 批准号:
23K15543 - 财政年份:2023
- 资助金额:
$ 6.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING
SBIR 第二阶段,主题 429:自体和同种异体细胞治疗制造的新范式
- 批准号:
10976161 - 财政年份:2023
- 资助金额:
$ 6.28万 - 项目类别:
Planning a phase I study of minor salivary gland derived autologous MSCs for prevention of long-term radiation induced xerostomia
计划对小唾液腺来源的自体 MSC 进行 I 期研究,以预防长期辐射引起的口干症
- 批准号:
10720234 - 财政年份:2023
- 资助金额:
$ 6.28万 - 项目类别:
Evaluation of a therapeutic vaccination strategy with motif neoepitope peptide-pulsed autologous dendritic cells for non-small cell lung cancer patients harboring a charged HLA-B binding pocket.
使用基序新表位肽脉冲的自体树突状细胞对携带带电 HLA-B 结合袋的非小细胞肺癌患者的治疗性疫苗接种策略进行评估。
- 批准号:
10721983 - 财政年份:2023
- 资助金额:
$ 6.28万 - 项目类别: